amaurosis


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

am·au·ro·sis

 (ăm′ô-rō′sĭs)
n.
Total loss of vision, especially when occurring without pathological changes to the eye.

[Greek amaurōsis, from amauroun, to make dim, from amauros, dark.]

am′au·rot′ic (-rŏt′ĭk) adj.

amaurosis

(ˌæmɔːˈrəʊsɪs)
n
(Medicine) pathol blindness, esp when occurring without observable damage to the eye
[C17: via New Latin from Greek: darkening, from amauroun to dim, darken]
amaurotic adj

am•au•ro•sis

(ˌæm ɔˈroʊ sɪs)

n.
partial or total loss of sight, esp. in the absence of a gross lesion or injury.
[1650–60; < Greek: darkening, hindrance to sight]
am`au•rot′ic (-ˈrɒt ɪk) adj.

amaurosis

a condition of partial or total blindness, caused by a disease of the optie nerve. — amaurotic, adj.
See also: Blindness
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.amaurosis - partial or total loss of sight without pathology of the eyeamaurosis - partial or total loss of sight without pathology of the eye; caused by disease of optic nerve or retina or brain
vision defect, visual defect, visual disorder, visual impairment - impairment of the sense of sight
Translations
Amaurose
References in periodicals archive ?
El termino migrana retiniana (conocida tambien como migrana oftalmica, optica o de la via visual anterior) fue usado para describir la perdida de agudeza visual unilateral transitoria (Amaurosis Fugaz) o la presencia de escotomas monoculares de duracion corta (menos de 1 hora) y recuperacion total, asociados a cefalea.
The reasons for examination were varied: 42% had symptoms of transient ischemic attacks, 36% had symptoms of stroke, and 22% had symptoms of amaurosis fugax.
"A related condition, called amaurosis fugax, causes an intermittent blurring of vision for hours to days before a full-blown attack of central retinal artery occlusion.
A 62-year-old white woman presented to her physician following 3 episodes of transient blindness (amaurosis fugax) in her right eye.
The human condition, called Leber congenital amaurosis (LCA), results in degeneration of the retina and near total blindness in infancy.
Patient 1 was a 19-year-old woman with septo-optical dysplasia, diabetes insipidus, and amaurosis. Her admission was for clinical signs of hypocortisolism.
All had experienced a hemispheric transient ischemic attack (TIA), amaurosis fugax (blindness of one eye, often like a shade pulled down over it) lasting less than 24 hours, or a nondisabling stroke within the previous 4 months.
History of stroke: The major source of controversy in assessing the history of stroke is whether transient ischaemic attacks (TIA) (31/24/0) or amaurosis fugax (22/32/0) should be considered as strokes.
The first patient was dosed in the Phase 2/3 ILLUMINATE trial in patients with sepofarsen in Leber's Congenital Amaurosis 10 (LCA10) at the beginning of the second quarter of 2019.
Allergan (AGN) and Editas Medicine (EDIT) announced initial data from the ongoing natural history study to evaluate patients with Leber congenital amaurosis 10, or LCA10, a rare form of blindness caused by mutations in the CEP290 gene.
Our treatment focused on a severe retinal disease that affects children and adults called Leber Congenital Amaurosis. For this particular condition, there are two central benefits.
The clinical presentations included dizziness, amaurosis, numbness of limbs, dyskinesia, aphasia, and transient ischemic attack (TIAs).